At what ages and under which risk factors should children be screened for hyperlipidemia (fasting lipid panel) and glucose abnormalities (fasting plasma glucose or HbA1c)?

When to Screen Children for Hyperlipidemia and Glucose

Screen all children for hyperlipidemia once between ages 9-11 years and again between 17-21 years, with earlier selective screening starting at age 2 years for those with family history of premature cardiovascular disease or severe hypercholesterolemia. For glucose screening, target children ≥10 years with obesity (BMI ≥95th percentile) or other metabolic risk factors 1, 2, 3.

Hyperlipidemia Screening Strategy

Universal Screening Ages

• Ages 9-11 years: First universal screening with fasting or nonfasting lipid panel (non-HDL-C or LDL-C) 1, 3, 4
  • This timing is chosen because lipid levels stabilize before the physiological 10-20% decline during puberty
  • Atherosclerotic process appears to accelerate at this age
• Ages 17-21 years: Second universal screening 1, 3

The 2018 AHA/ACC guidelines and 2011 NHLBI Expert Panel both support this universal approach, though it carries a IIb recommendation level (may be reasonable) 1, 3. The 2022 Canadian guidelines recommend universal screening once within the first decade of life 2.

Selective Screening (Higher Priority - Start Earlier)

Begin at age 2 years if any of the following apply 1, 3:

Family History Criteria:

• Parent, grandparent, aunt, uncle, or sibling with:
  • Myocardial infarction, angina, stroke, or sudden cardiac death before age 55 (males) or 65 (females)
  • Documented coronary artery disease, peripheral vascular disease, or cerebrovascular disease
• Parent with total cholesterol ≥240 mg/dL or known primary hypercholesterolemia
• Known familial hypercholesterolemia in the family

Medical Risk Factors (any age ≥2 years):

• Obesity (BMI ≥95th percentile)
• Hypertension
• Type 1 or type 2 diabetes
• Chronic kidney disease
• Smoking
• Moderate- or high-risk medical conditions 3

Screening Protocol for Hyperlipidemia

1. Initial test: Fasting lipid panel (preferred) or nonfasting non-HDL-C 3
2. If abnormal: Repeat fasting lipid panel on a separate occasion (between 2 weeks and 3 months later)
3. Average the two results for clinical decision-making 2, 3

Abnormal thresholds requiring follow-up:

• Non-HDL-C ≥3.75 mmol/L (145 mg/dL) 2
• LDL-C ≥3.4 mmol/L (130 mg/dL) 2
• Total cholesterol ≥5.2 mmol/L (200 mg/dL) 2

Special Consideration: Familial Hypercholesterolemia

For children at risk for FH, the 2017 AACE/ACE guidelines recommend screening at age 3 years, again between ages 9-11, and again at age 18 5. When FH is identified in a child, perform reverse-cascade screening of first-, second-, and third-degree biological relatives 1, 4.

Glucose Screening Strategy

Target Population for Glucose Screening

Screen children ≥10 years of age with the following 3:

Primary indication:

• Obesity (BMI ≥95th percentile) or overweight (BMI ≥85th percentile) 3

Additional risk factors that warrant screening:

• Family history of type 2 diabetes in first- or second-degree relative
• Signs of insulin resistance (acanthosis nigricans, hypertension, dyslipidemia, polycystic ovary syndrome)
• Maternal history of gestational diabetes
• High-risk race/ethnicity (African American, Latino, Native American, Asian American, Pacific Islander)

Screening Tests for Glucose Abnormalities

Acceptable screening methods:

• Fasting plasma glucose
• HbA1c
• Oral glucose tolerance test (2-hour post-load glucose)

Screening interval: Every 3 years if initial screening is normal, or more frequently if risk factors worsen 3

Key Clinical Pitfalls to Avoid

1. Don't skip screening during ages 12-16 years: The 2011 NHLBI guidelines specifically recommend against routine screening during this period due to decreased sensitivity and increased false-negative results from pubertal lipid changes 3. Wait until ages 17-21 for the second universal screen.

2. Don't rely solely on family history: Selective screening based on family history alone misses 30-60% of children with dyslipidemia, particularly because accurate family history is often unavailable 2.

3. Don't screen before age 2 years for lipids: Lipid levels are unstable and not predictive before this age 3.

4. Don't use single measurements: Always confirm abnormal lipid results with a second fasting measurement and average the two values before making treatment decisions 2, 3.

5. Don't forget reverse-cascade screening: When you identify a child with severe hypercholesterolemia, screen extended family members to identify undiagnosed adults with FH before they develop cardiovascular events 1, 4.

Practical Implementation

For a typical well-child visit approach:

• Ages 2-8 years: Screen only if risk factors present
• Ages 9-11 years: Universal lipid screening for all children
• Age ≥10 years: Add glucose screening if obesity or metabolic risk factors present
• Ages 12-16 years: Screen only if new risk factors emerge
• Ages 17-21 years: Universal lipid screening for all adolescents

The evidence supporting universal screening is moderate (Level B), while selective screening based on risk factors has stronger support (Level A for certain populations) 1, 3. The Canadian approach of screening once in the first decade may be more practical in healthcare systems with limited routine adolescent visits 2.